CVS Health expands availability of resources to prevent opioid misuse amid pandemic

Top of the article

Innovative prevention efforts aim to make an impact in a time of reduced personal contact

WOONSOCKET, R.I. — CVS Health (NYSE: CVS) today announced new and expanded programs to help prevent opioid misuse, which come as the pandemic has presented challenges to delivering traditional drug abuse prevention programs for young people. The company's newest initiative increases access to digital prevention education resources tailored for the current learning environment.

Working with Discovery Education, CVS Health has launched a suite of no-cost digital resources that empower educators to discuss the facts about prescription and illicit drug misuse with students in either a classroom or virtual learning setting. The standards-based curriculum, called Dose of Knowledge, features Chicago Bears wide receiver Allen Robinson and U.S. Women's National Soccer goalkeeper Adrianna Franch. The initiative builds on CVS Health's successful pharmacist-led prevention education program by incorporating the perspective of several CVS pharmacists.

"The pandemic has brought new complexities to the way in which prevention and treatment services are provided, but early intervention remains as important as ever," said Troyen Brennan, M.D., Chief Medical Officer, CVS Health. "Our work with Discovery Education accounts for the new definition of a 'classroom,' and delivers the same impactful resources to students regardless of their circumstances."

The CVS Health Foundation, a private charitable organization created by CVS Health, has also committed nearly $3 million in new grants to address opioid misuse and support treatment in local communities, including:

  • More than $1 million to the National Association of Free and Charitable Clinics to support addiction treatment and other patient services in 17 states;

  • $1 million to America's Essential Hospitals to support office-based addiction treatment for more than 30 safety-net hospitals and facilitate a collaborative to share learnings with member hospitals;

  • $500,000 to Easterseals to support mental health and addiction recovery services for veterans; and

  • Nearly $100,000 to Young People In Recovery to create a digital life-skills curriculum to help young people rebuild their lives.

In addition to the impact these investments aim to have, a new report from the National Association of Community Health Centers is outlining the impact in this area of previous investments made by the CVS Health Foundation.

CVS Health is also building on its commitment to increase access to the opioid overdose-reversal drug naloxone, also known as Narcan. The medication has already been made available without an individual prescription, under a standing order or similar regulation, to CVS Pharmacy patients nationwide. Now, CVS Pharmacy is offering free delivery of naloxone nasal spray in all 30 states where regulations permit, as part of the company's free one- to two-day prescription delivery offering that was implemented shortly after the pandemic began.

On Saturday, October 24, CVS Health will participate in the Drug Enforcement Association's National Prescription Take Back Day, with events at select CVS Pharmacy locations. These events are just part of CVS Health's everyday efforts to reduce the availability of unneeded or unwanted controlled substances, which also include more than 2,800 CVS Pharmacy locations that offer permanent safe medication disposal kiosks. By the end of 2020, CVS Health will have installed more than 2,900 safe medication disposal units in CVS Pharmacy locations and donated more than 1,000 disposal units to local law enforcement. Together, these units have collected nearly two million pounds of unwanted medication, including opioids, removing these medications from homes where they could be diverted or abused. All CVS Pharmacy locations that do not offer in-store safe medication disposal units continue to offer no-cost DisposeRx drug disposal packets with all opioid first-fill prescriptions that can facilitate safe medication disposal at home.

About CVS Health

CVS Health employees are united around a common goal of becoming the most consumer-centric health company. We're evolving based on changing consumer needs and meeting people where they are, whether that's in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings from HealthHUB locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we're transforming health at www.cvshealth.com.

About the CVS Health Foundation

The CVS Health Foundation is a private charitable organization created by CVS Health that works to build healthier communities, enabling people of all ages to lead healthy, productive lives. The Foundation provides strategic investments to nonprofits throughout the U.S. who help increase community-based access to health care for underserved populations, create innovative approaches to chronic disease management and provide tobacco cessation and youth prevention programming. We also invest in scholarship programs that open the pathways to careers in pharmacy to support the academic aspirations of the best and brightest talent in the industry. Our philanthropy also extends to supporting our colleagues' spirit of volunteerism through Volunteer Challenge Grants to nonprofits where they donate their time and fundraising efforts. To learn more about the CVS Health Foundation and its giving, visit www.cvshealth.com/social-responsibility.

Media contact

Erin Shields Britt
Corporate Communications
Erin.Britt@CVSHealth.com

A young female student is seen wearing headphones and a face mask using a computer.
Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
On
Audience

Our opioid response: Public policy

A pharmacy shelf displaying boxes of naloxone nasal spray.

As a leading stakeholder in health care, CVS Health works with advocacy organizations and elected leaders to recommend new and enhanced policies that will help address opioid misuse and abuse.  

Through this advocacy work, we’ve also been able to offer access to naloxone, the lifesaving opioid overdose-reversal drug, by establishing a standing order or similar protocol at CVS Pharmacy locations in all 50 states and the District of Columbia. This protocol allows patients to obtain naloxone at the pharmacy counter without having to first obtain an individual prescription from a physician.

Additional public policy action we’ve taken includes:

  • CVS Health spearheaded a 2017 joint industry letter to the Trump Administration and key members of Congress. The letter recognized the need for pharmacy care providers to come together to address the opioid epidemic and highlighted the steps companies in the industry have taken, as well as our shared commitment to a public-private partnership to help solve the national health care crisis of opioid abuse.

  • Restrictions on the initial quantity of an opioid that can be prescribed. CVS Health has supported legislation in states around the country that restricts the initial quantity of an opioid that can be prescribed.

  • Support for legislation mandating the electronic transmission of prescriptions. We believe this would reduce the likelihood of diversion through forged or fraudulent hard copy prescriptions.

  • Support for a national prescription drug monitoring program. We believe this would harmonize state requirements and more easily allow states to share data, which could prevent provider shopping across state lines. It would also set uniform expectations for health care providers and law enforcement.

CVS Health enhances prescription drug security and disposal in Massachusetts to help promote safer communities

Top of the article

Completes installation of time delay safe technology in all 446 CVS Pharmacy locations as part of effort to help reduce robbery incidents

Company also adds 50 in-store safe medication disposal units to help combat misuse and diversion of unused medication across the state

WOONSOCKET, R.I. — As part of an ongoing commitment to helping build healthier and safer communities, CVS Health (NYSE: CVS) today announced the expansion of two initiatives aimed at reducing the potential for misuse and diversion of prescription medications in Massachusetts.

CVS Pharmacy, the retail division of CVS Health, completed the installation of time delay safe technology in all its 446 Massachusetts locations, including those in Target stores. The safes are anticipated to help prevent pharmacy robberies and the resulting diversion of controlled substance medications, including opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to open the safe. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

Further enhancing the company's efforts to help prevent opioid diversion and misuse, CVS Pharmacy also announced the addition of 50 new safe medication disposal units placed in select stores throughout Massachusetts. The new units join another 106 secure disposal kiosks previously installed in CVS Pharmacy locations in the state and another 43 units previously donated to Massachusetts law enforcement agencies. CVS Pharmacy plans to install an additional 6 units in stores by year-end.

"While our nation and our company focus on COVID-19 treatment, testing and other measures to prevent community transmission of the virus, the misuse of prescription drugs remains an ongoing challenge in Massachusetts and elsewhere that warrants our continued attention," said John Hering, Region Director for CVS Health. "These steps to reduce the theft and diversion of opioid medications bring added security to our stores and more disposal options for our communities."

"We commend CVS Health for its continued commitment to address the opioid crisis and welcome the expansion of safe and convenient medication disposal in our communities," said Health and Human Services Secretary Marylou Sudders. "We are proud of the progress made in combatting addiction and reducing the rate of opioid related deaths in Massachusetts, and we know this work is as essential as ever especially as we navigate an unprecedented pandemic. We value the strategic alignment and ongoing investment from partners like CVS Health in our collective, continued fight against opioid addiction."

Time delay safes help reduce pharmacy robberies

CVS Health first implemented time delay safe technology in 2015 in CVS Pharmacy locations across Indianapolis, a city experiencing a high volume of pharmacy robberies at the time. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where time delay safes had been installed.

Since then, the company has introduced time delay safes in 4,760 CVS Pharmacy stores across 15 states and the District of Columbia, resulting in a 50 percent decline in robberies at CVS pharmacies in those local communities.

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations in Massachusetts with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

50 Massachusetts safe medication disposal units added

The expansion of CVS Pharmacy's safe medication disposal program in 50 Massachusetts stores continues the company's commitment to providing increased year-round access to safer, easier and more convenient options for removing unneeded prescription drugs from the home.

"When patients leave unused medications especially opioids in a medicine cabinet, there is a risk they might be misused, diverted or come in contact with unsupervised children, other family members or guests in the home," said Tom Davis, Vice President of Pharmacy Professional Services at CVS Health. "It is critical that medications are taken only as prescribed, and we believe safe medication disposal is an important way to help prevent misuse."

In 2020, the company is adding an additional 1,000 in-store safe medication disposal units to the 2,500 units currently in CVS Pharmacy locations nationwide. Over the past several years, the company has also donated over 1,000 units to local law enforcement. Together, these existing medication disposal units have collected more than 1.8 million pounds of unwanted medications, including over 90,000 pounds in Massachusetts, that might otherwise have been diverted, misused or ended up in the water supply.

Located in the pharmacy area of the CVS store and similar in design to a postal box, the safe medication disposal units allow customers to drop off unused prescriptions in a container or in sealed plastic bags if liquids or multiple medications are included.

Additionally, CVS Pharmacy locations that do not offer a safe medication disposal kiosk offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when warm water and the DisposeRx powder are added to a container, the combination breaks down medications including powders, pills, capsules, tablets, liquids or patches to a non-divertible biodegradable gel, allowing for safe disposal in the trash at home.

Given its national reach and local presence, CVS Health is uniquely positioned to help address prescription opioid misuse and abuse with an enterprise-wide approach. To learn more about CVS Health's efforts, visit the company's Opioid Response website.

For downloadable safe medication disposal units and time delay safe media assets, including photos and B-roll footage, please visit the Media Resource Center.

About CVS Health

CVS Health employees are united around a common goal of becoming the most consumer-centric health company. We're evolving based on changing consumer needs and meeting people where they are, whether that's in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings from HealthHUB locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we're transforming health at www.cvshealth.com

Media contact

Joe Goode
401-378-5220
Joseph.Goode@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience

Addressing opioid use disorder through treatment centers instead of prisons

Addressing opioid use disorder through treatment centers instead of prisons
Bottom of the article

Local people with local solutions — that’s what we’re all about at Healthy Communities News. In this episode, our host, Hilary Russo, travels to Virginia and North Carolina to check out two communities taking creative approaches to address opioid use disorder. We’ll hear about these innovative solutions from the folks on the ground putting them into action and get a glimpse into recovery from Wanda Jenkins, who is using her experience with opioid use disorder to help others.


A helping hand from someone who’s been there: Gina’s story

In this episode’s podcast, we meet Gina Musa, who advocates passionately for community members in rural North Carolina struggling with opioid use disorder. A former sex worker, Gina draws on her own experience with addiction and recovery to connect people with much-needed resources and support. Today, she is a Linkage to Care Coordinator for the North Carolina Harm Reduction Coalition, a job funded by an Aetna Foundation grant.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off
Assets
CSR Pillars
Audience
Narrative themes

CVS Health combines “Guardian Angel” and Unite Us programs to support opioid overdose victims in North Carolina

CVS Health combines “Guardian Angel” and Unite Us programs to support opioid overdose victims in North Carolina
Top of the article

Collaboration with Unite Us also expanded to serve vulnerable community members in New Orleans and Tampa Bay

WOONSOCKET, R.I. — According to the Centers for Disease Control and Prevention (CDC), more than 130 people die every day from opioid overdoses. For those individuals who suffer an overdose and are fortunate enough to survive, the event can serve as a turning point on the road to recovery.

To help people when they are potentially the most open to treatment, CVS Health (NYSE: CVS) is enhancing the "Guardian Angel" program, which is designed to help individuals who suffer an opioid-related overdose. In North Carolina, the Guardian Angel program will now be supported by CVS Health's collaboration with Unite Us, a leading social care coordination platform. Through this combination, clinical case managers can use the Unite Us network of social services to connect individuals with non-clinical support that can aid their recovery, such as community resources to help with housing, food insecurity and financial assistance.

"The Guardian Angel program already has a high engagement rate of about 50 percent because it connects with people in a compassionate way during the time when they need it most," said Dr. Daniel Knecht, Vice President, Health Strategy and Innovation, CVS Health. "We recognize that whether a person is successfully able to fight addiction is not solely determined by the medical treatment that they receive. Through the Unite Us network of social care providers, people can more easily access support within their community and have a better chance of recovery."

Since the Guardian Angel program was launched by Aetna, a CVS Health company, in 2018, clinical case managers have connected with nearly 1,000 Aetna members who have suffered an overdose as well as their families, providing education and resources around the effectiveness of evidence-based addiction treatment. Members who have been contacted live in every part of the country and range in age from 16 to 79 years old (with an average age of 45).

The clinical case managers that participate in the Guardian Angel program will also be a part of the NCCARE360 network in North Carolina. NCCARE360 is the first statewide network that unites health care and human services organizations with a shared technology, Unite Us, that enables a coordinated, community-oriented, person-centered approach for delivering care. NCCARE360 is planned to be available statewide in North Carolina by the end of 2020.

Helping improve community health in New Orleans and Tampa Bay

In addition to integrating the Guardian Angel and Unite Us programs in North Carolina, CVS Health and Unite Us also launched programs in New Orleans and Tampa Bay, Florida to help Aetna's Medicaid and Dual Eligible (people eligible for both Medicaid and Medicare) members more easily access social services within their community. Working with Unite Us, Aetna's Dual-Eligible Special Needs Plan (DSNP) members in these communities can receive help from a wide range of services through local organizations - transportation, food assistance and meal delivery, adult day care, employment services and housing support, among others.

"Improving health starts at the community level, and most of that work needs to take place outside of a doctor's office," said Dr. Garth Graham, Vice President, Community Health & Impact, CVS Health. "Our collaboration with Unite Us allows us to support some of the most vulnerable members of the community, providing them with the local resources that they need to improve their everyday lives."

CVS Health's continued work with Unite Us is a key component of Destination: Health, a series of business programs focused on helping people improve their health outside of a clinical setting.

"We're excited and inspired by the progress and impact of the Destination Health initiative as it expands through the country," says Taylor Justice, Co-Founder and President of Unite Us. "It is encouraging to see the local community support as our teams continue to launch networks in Tampa and New Orleans to support Aetna's DSNP members, as well as combining the Guardian Angel and Unite Us programs in North Carolina."

About CVS Health

CVS Health employees are united around a common goal of becoming the most consumer-centric health company in the world. We're evolving based on changing consumer needs and meeting people where they are, whether that's in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings from HealthHUB locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we're transforming health at http://www.cvshealth.com.

Media contact

Ethan Slavin
860-273-6095
SlavinE@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
Off
Campaign
CSR Pillars
Audience

CVS Health Completes Rollout of Time Delay Safes in All of Its Virginia Pharmacies

Top of the article

New safes for controlled substances anticipated to help reduce robbery incidents

All 353 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 353 CVS Pharmacy locations in Virginia, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

CVS Pharmacy expects these time delay safes to help deter pharmacy robberies including those involving opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to be able to open the safe. CVS Pharmacy first implemented time delay safes in Indianapolis, a city experiencing at the time a high volume of pharmacy robberies, in 2015. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where the time delay safes had been installed.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of incidents in our Virginia stores," said Dick Dakessian, Division Leader for CVS Pharmacy. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse, diversion and abuse.

The company, for example, has expanded its Safe Medication Disposal Program in Virginia, completing the installation of 72 drug disposal kiosks in select CVS Pharmacy locations in communities across the state, adding to the 78 units previously donated to local law enforcement.

In 2020, the company will add 1,000 in-store safe medication disposal units to the more than 1,800 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the 1,000 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications, including 66,600 pounds in Virginia.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company is collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Pharmacy

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Announces $750K in New Funding for California Harm Reduction Coalition

Top of the article

Three-year partnership will help support critical resources to address prescription opioid abuse across the state

OAKLAND, Calif. As part of its commitment to building healthier communities, CVS Health (NYSE: CVS) today announced it will be providing $750,000 over the next three years to the national Harm Reduction Coalition to improve the health and wellness of California residents impacted by prescription opioid misuse and abuse.

Harm Reduction Coalition, or HRC, is a national capacity-building and advocacy organization that promotes the health and dignity of individuals and communities affected by drug abuse and drug-related policies and provides a critical voice for those in the most vulnerable communities. The new funding from CVS Health will help support HRC as they tackle critical health issues faced by the California community related to prescription opioid misuse and abuse.

"We can help improve the health outcomes of our communities by strengthening our local support and empowering local organizations that are developing innovative solutions," said Kristen Miranda, California Market President for Aetna, a CVS Health company. "We know that so many communities across the country including in California have been impacted by widespread prescription opioid misuse and abuse. Our work with the HRC will support their efforts to address several elements of this significant public health issue in California and help local residents on their path to better health."

The funding will support HRC's Community Engagement Network to Expand Resources (CENTER) Initiative a three-year, state-wide effort designed to expand, develop and deepen harm reduction services throughout California. CENTER will be focused on convening diverse stakeholders to address drug-related stigmas, supporting syringe services programs with training and technical assistance, hosting state and national conferences and developing culturally relevant resources as a means to be better equipped to respond to the needs of people who misuse and abuse prescription drugs, their families, and impacted communities in California.

The CVS Health grant will be highlighted at a Harm Reduction Coalition training event and discussion taking place December 11 and 12 at the University of California, Fresno Center. The event is open to community members and service providers in the Central Valley that are focused on evidence-based strategies to address issues related to prescription opioid misuse and abuse.

"We have over 25 years of experience preventing overdose and drug-related harms through resources and education that are rooted in evidence and compassion," said Dr. Taeko Frost, Senior Director of Innovation and Strategy for Harm Reduction Coalition. "We know that harm reduction programs have been operating on shoestring budgets for years, only reaching the people most at risk of overdose. The CENTER Initiative will allow us to strengthen those programs through training and capacity-building, to build partnerships with other local programs, including health care providers and drug treatment access points, and to create a comprehensive statewide network for providers who can meaningfully engage with at-risk community members."

Building Healthier Communities by Addressing Prescription Opioid Misuse and Abuse

The grant is part of CVS Health's Building Healthier Communities initiative, which is a commitment to making community health and wellness central to the newly combined company's charge for a better world. Through Building Healthier Communities, CVS Health and its charitable foundations will support a range of initiatives and non-profit organizations across three categories: improving local access to affordable quality care; impacting public health challenges; and partnering with local communities.

One of the primary public health issues the company is addressing is the impact of the misuse and abuse of prescription opioids in communities around the country. CVS Health and Aetna's expansive reach, expertise and access to local communities position us to help fight prescription opioid abuse for the people we serve. Our comprehensive strategy focused on prevention, intervention and support, builds on years of innovative programs and allows us to identify new opportunities for impact. The company has made an enterprise-wide commitment to help address the inappropriate use of prescription opioids by designing programs that increase access to safe medication disposal, encourage appropriate utilization, educate patients at the pharmacy and teens and parents in communities, expand access to life-saving antidotes, work with providers to ensure they are following evidence-based opioid prescribing guidelines, and support local recovery programs.

This grant is part of CVS Health's commitment to investing in California's health care delivery system, reflected in the November 2018 agreement between CVS Health and California's Department of Managed Health Care (DMHC).

About Harm Reduction Coalition

Harm Reduction Coalition is a national advocacy and capacity-building organization that promotes the health and dignity of individuals and communities impacted by drug use. Our efforts advance harm reduction policies, practices and programs that address the adverse effects of drug use including overdose, HIV, hepatitis C, addiction, and incarceration. Recognizing that social inequality and injustice magnify drug-related harm and limit the voice of our most vulnerable communities, we work to uphold every individual's right to health and well-being and their competence to participate in the public policy dialogue.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Ethan Slavin
860-273-6095
SlavinE@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Launches Transform Oncology Care Program to Help Improve Patient Outcomes and Lower Overall Costs

Top of the article

New precision medicine strategy uses the latest genomics science and technology to help providers identify and start their patients on the best cancer treatment, faster

Comprehensive oncology management program includes enterprise capabilities to help address significant challenges at every point of the cancer care journey

WOONSOCKET, R.I. CVS Health (NYSE: CVS) today announced Transform Oncology Care , anchored on a first-of-its-kind precision medicine strategy for payors. The program uses genomic testing results at the point-of-prescribing to help patients start on the best treatment, faster and in addition, matches eligible patients to clinical trials. Transform Oncology Care also uses the Company's local footprint and unique assets to improve patient outcomes and lower overall costs at every point of the cancer care journey.

"Timing in cancer care is everything and when a patient does not get started on the right treatment it can result in progression and higher costs," said Alan Lotvin, M.D., Executive Vice President and Chief Transformation Officer, CVS Health. "We are the first company working to make the latest in precision medicine accessible to more patients and further empower informed treatment decision-making based on a patient's genetic profile to give them the best chance for successful treatment and improved quality-of-life."

Connecting Guidelines to Genetic Testing for the Best Treatment, Faster

The innovative precision medicine strategy, delivered in close coordination with oncologists, uses results of broad-panel gene sequencing tests and the latest National Comprehensive Cancer Network (NCCN) treatment and supportive care guidelines to help oncologists identify and start their patients on the most precise, appropriate treatment regimen based on their clinical and genetic profiles. Therapeutic regimens that align to NCCN guidelines, including those matched with the results of the broad-panel gene sequencing tests, will automatically receive prior authorization approval, speeding time to start of the therapy for patients. The strategy is enabled by an innovative collaboration with Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

"CVS Health is making great strides in advancing patient care, and we are thrilled to contribute the benefits of genomic testing to these efforts," said Ryan Fukushima, Chief Operating Officer of Tempus. "We believe this collaboration has real potential to personalize treatment for patients while also reducing the total cost of care."

Today, the majority of cancers when diagnosed early can be effectively managed, treated or even cured.https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf For patients diagnosed with late-stage cancers, however, many can benefit from advanced genomic testing, yet very few eligible patients receive this type of testing today. This can inhibit the start of the most appropriate treatment and result in cancer progression and higher costs. For these patients, a web-based provider portal, built into the e-prescribing workflow, informs oncologists of the availability of Tempus' broad-panel gene sequencing tests at diagnosis, which are more comprehensive than the single-gene tests that are used today. The broad-panel tests identify a patient's genomic variants and the therapeutic options specific to their molecular and clinical profile. The testing results also match and help support the rapid enrollment of eligible patients in local clinical trials through Tempus' proprietary platform, facilitating broader access to experimental therapies. In addition, the portal provides oncologists real-time access to the latest NCCN guidelines at the point-of-prescribing.

The program includes CVS Health nurse-led care management, integrated with payor's existing programs, to create a more personalized experience for patients and their caregivers and close existing gaps in care. In addition, payors can adopt value-based contracts that employ provider networks to drive high-quality care and lower costs. Transform Oncology Care also uses the CVS Health's accessible, local footprint, connected data and integrated systems to help better identify and intervene with patients who could benefit from preventive or screening services.

Transform Oncology Care is available to other health plans. Aetna has adopted the program for fully insured commercial populations and is rolling it out with participating Aetna provider networks in 12 states.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Christina Beckerman
401-770-8868
Christina.Beckerman@cvshealth.com

Investor Contact

Valerie Haertel
401-770-4050
Valerie.Haertel@cvshealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
11
Display Hero
Off
Audience

CVS Health Completes Rollout of Time Delay Safes in All of Its West Virginia Pharmacies

Top of the article

New safes for controlled substances anticipated to help reduce robbery incidents

All 58 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 58 CVS Pharmacy locations in West Virginia, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

CVS Pharmacy expects these time delay safes to help deter pharmacy robberies including those involving opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to be able to open the safe. CVS Pharmacy first implemented time delay safes in Indianapolis, a city experiencing at the time a high volume of pharmacy robberies, in 2015. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where the time delay safes had been installed.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of incidents in our West Virginia stores," said Dick Dakessian, Division Leader for CVS Pharmacy. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse, diversion and abuse.

The company, for example, has expanded its Safe Medication Disposal Program in West Virginia, completing the installation of 27 drug disposal kiosks in select CVS Pharmacy locations in communities across the state, adding to the five units previously donated to local law enforcement.

In 2020, the company will add 1,000 in-store safe medication disposal units to the more than 1,800 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the 1000 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications, including 7,600 pounds in West Virginia.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company is collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Completes Rollout of Time Delay Safes in All of Its North Carolina Pharmacies

Top of the article

New safes for controlled substances anticipated to help reduce robbery incidents

All 375 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 375 CVS Pharmacy locations in North Carolina, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

CVS Pharmacy expects these time delay safes to help deter pharmacy robberies including those involving opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to be able to open the safe. CVS Pharmacy first implemented time delay safes in Indianapolis, a city experiencing at the time a high volume of pharmacy robberies, in 2015. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where the time delay safes had been installed.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of incidents in our North Carolina stores," said Brian Bosnic, Division Leader for CVS. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse, diversion and abuse.

The company, for example, has expanded its Safe Medication Disposal Program in North Carolina, completing the installation of 65 drug disposal kiosks in select CVS Pharmacy locations in communities across the state, adding to the 42 units previously donated to local law enforcement.

In 2020, the company will add 1,000 in-store safe medication disposal units to the more than 1,800 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the 1000 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications, including 47,000 pounds in North Carolina.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company is collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Pharmacy

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Brent Burkhardt
410-299-2528
bburkhardt@tbc.us

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience